Table 3.
Analysis of Variance (ANOVA) between the women who were diagnosed with and undergoing chemotherapy treatment for breast cancer (BC) and healthy control (HC) groups on psychosocial measures of cognitive functioning, depression, anxiety, and perceived stress.
| Variable | Mean (± SD) | Range | F | p | ƞ2 |
|---|---|---|---|---|---|
| FACT-Cog total | |||||
| BC | 103.9 (19.7) | 62–138 | 21.7 | 0.001*** | 0.4 |
| HC | 131.4 (12.1) | 97–143 | |||
| Perceived cognitive impairments | |||||
| BC | 55.1 (13.1) | 19–72 | 13.9 | 0.001*** | 0.3 |
| HC | 69.1 (6.2) | 52–75 | |||
| Perceived cognitive abilities | |||||
| BC | 22.3 (6.1) | 12–35 | 21.6 | 0.001*** | 0.4 |
| HC | 31.4 (4.9) | 19–36 | |||
| Comments from others | |||||
| BC | 1.1 (1.5) | 0–5 | 4.1 | 0.05* | 0.1 |
| HC | 0.2 (0.4) | 0–1 | |||
| Quality of life | |||||
| BC | 11.6 (3.7) | 1–16 | 11.8 | 0.002** | 0.3 |
| HC | 15.2 (1.6) | 10–16 | |||
| CES-D | |||||
| BC | 11.9 (7.7) | 0–32 | 5.4 | 0.03* | 0.1 |
| HC | 6.1 (1.9) | 0–24 | |||
| PROMIS Bank v1.0–anxiety | |||||
| BC | 50.8 (7.7) | 33–63 | 1.4 | 0.3 | 0.04 |
| HC | 47.8 (6.4) | 33–59 | |||
| PSS | |||||
| BC | 13.7 (4.9) | 6–22 | 0.9 | 0.4 | 0.03 |
| HC | 12.1 (4.9) | 3–19 | |||
F, F-test, ƞ2, eta-squared, *p < 0.05, **p < 0.01, ***p < 0.001.
FACT-Cog, The Functional Assessment of Cancer Therapy-Cognitive Function; CES-D, Center for Epidemiologic Studies Depression Scale; PROMIS, Patient-Reported Outcomes Measurement Information System Bank v1.0–anxiety; PSS, Perceived Stress Scale.